ZEVRA THERAPEUTICS, INC.

By person

22 insiders · 175 transactions

5.9×

Neil F. McFarlane holds 5.9 times base salary in stock. $4.31M of shares against $729.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Neil F. McFarlane last reported holding, valued at $11.13, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Delaware Street Capital Master Fund, L.P. entity

10% owner

$8.28M (5)

—

+$8.28M

4,095,914

6.90%

$45.58M

+179.4%

McFarlane Neil F.

President and CEO

—

$1.92M (5) scheduled

−$1.92M

387,225

0.6521%

$4.31M

+674.5%

Thompson Rahsaan

Chief Legal & Compliance

—

$1.19M (5) scheduled

−$1.19M

37,569

0.0633%

$418.06K

—

Bode John B

Director

$285.86K (10)

—

+$285.86K

123,400

0.2078%

$1.37M

—

Mickle Travis C

President & CEO

$258.80K (24)

—

+$258.80K

752,182

1.27%

$8.37M

+39.3%

Schafer Joshua

CCO

$17.20K (3)

$208.83K (3) scheduled

−$191.63K

62,278

0.1049%

$693.01K

+5,301%

Shih Alvin

Director

$157.80K (1)

—

+$157.80K

20,000

0.0337%

$222.55K

—

Pascoe Richard W

Chief Executive Officer

$136.44K (13)

—

+$136.44K

29,973

0.0505%

$333.53K

—

Cohen Daniel L

EVP, Govt. & Public Relations

$131.18K (15)

—

+$131.18K

3,450

0.0058%

$38.39K

—

Watton Corey Michael

Director

$11.78K (5)

$138.38K (1) scheduled

−$126.60K

1,800

0.0030%

$20.03K

—

Anderson Thomas

Director

$116.83K (2)

—

+$116.83K

20,000

0.0337%

$222.55K

—

Braun Samuel J

10% owner

$85.50K (1)

—

+$85.50K

3,070,000

5.17%

$34.16M

+0.3%

Plooster Matthew R

Director

$70.93K (5)

—

+$70.93K

19,617

0.0330%

$218.29K

—

Tierney David S

Director

$55.82K (8)

—

+$55.82K

10,835

0.0182%

$120.57K

—

Sangiovanni Timothy J.

SVP, Finance & Corp Controller

$17.60K (9)

$66.58K (3) scheduled

−$48.98K

29,590

0.0498%

$329.27K

—

Quartel Adrian W

Chief Medical Officer

—

$40.04K (1) scheduled

−$40.04K

9,723

0.0164%

$108.19K

+232.6%

Johnson Gordon K

Chief Business Officer

$36.81K (11)

—

+$36.81K

40,000

0.0674%

$445.11K

+1,900%

FAVORITO TAMARA A

Director

$28.19K (3)

—

+$28.19K

3,894

0.0066%

$43.33K

—

Clifton R. LaDuane

Former CFO & Treasurer

$105.16K (37)

$86.47K (1) scheduled

+$18.69K

143,515

0.2417%

$1.60M

—

Mickle Christal M M

Chief Development Officer

$8.20K (1)

—

+$8.20K

2,353,531

3.96%

$26.19M

+0.1%

Thompson Danny L

Director

—

190,747

0.3212%

$2.12M

+10.7%

Saluri Joseph

Director

—

20,899

0.0352%

$232.56K

+358.8%

ZEVRA THERAPEUTICS, INC.

By person

Individual transactions

What was left out